GenoSafe is a CRO providing analytical testing services for the evaluation of quality, safety and efficacy of Gene and Cell therapy candidates including : - GLP biodistribution, shedding and immunogenicity studies ; - QC testing, such as viral titration, safety and potency/efficacy testing ; - GCP bioanalysis of patient samples, including immunogenicity, shedding and gene expression studies. GenoSafe brings more than 15 years of experience in the development, qualification and validation of key analytical methods for product and sample testing.
| Website | http://www.genosafe.com |
| Revenue | $3 million |
| Employees | 52 (43 on RocketReach) |
| Founded | 2003 |
| Address | 1 Rue De L Internationale, Evry, Ile-de-France 91000, FR |
| Phone | +33 1 69 47 11 57 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Web Rank | 16 Million |
| Keywords | Quality Control Testing, Analytical Testing Services, Biopharmaceutical Testing, Contract Research Organization, Cro Services, Drug Development, Quality Assessment, Safety Testing, Efficacy Testing, Clinical Trial Testing, Regulatory Testing |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., QIAGEN, 10x Genomics, PacBio, Zymergen, Inc., Epigenomics AG +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular GenoSafe employee's phone or email?
The GenoSafe annual revenue was $3 million in 2026.
Alain Lamproye is the CEO of GenoSafe.
43 people are employed at GenoSafe.
GenoSafe is based in Evry, Ile-de-France.
The NAICS codes for GenoSafe are [32541, 325, 32, 3254].
The SIC codes for GenoSafe are [283, 28].